Dynamic roles of type I and type II IFNs in early infection with Mycobacterium tuberculosis

Journal of Immunology

Volumn 188, Issue 12, 2012, Pages 6205-6215

  Desvignes, Ludovic ^a   Wolf, Andrea J ^a,b   Ernst, Joel D ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CD11B ANTIGEN; CD40 ANTIGEN; CD86 ANTIGEN; GAMMA INTERFERON; GLYCOPROTEIN P 15095; INTERFERON; INTERFERON RECEPTOR; L SELECTIN; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 1;

ADAPTIVE IMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL GROWTH; BACTERIAL LOAD; BACTERIAL SURVIVAL; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; COLONY FORMING UNIT; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; IMMUNE RESPONSE; INNATE IMMUNITY; LUNG TUBERCULOSIS; MACROPHAGE; MEDIASTINUM LYMPH NODE; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; TARGET CELL;

ANIMALS; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; INTERFERON TYPE I; INTERFERON-GAMMA; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYCOBACTERIUM TUBERCULOSIS; TUBERCULOSIS, PULMONARY;

EID: 84862601432     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1200255     Document Type: Article

References (54)

1. Cooper, A. M., K. D. Mayer-Barber, and A. Sher. 2011. Role of innate cytokines in mycobacterial infection. Mucosal Immunol. 4: 252-260.
2. González-Navajas, J. M., J. Lee, M. David, and E. Raz. 2012. Immunomodulatory functions of type I interferons. Nat. Rev. Immunol. 12: 125-135.
3. Cooper, A. M., D. K. Dalton, T. A. Stewart, J. P. Griffin, D. G. Russell, and I. M. Orme. 1993. Disseminated tuberculosis in interferon gamma gene-disrupted mice. J. Exp. Med. 178: 2243-2247. (Pubitemid 23344885)
4. Dupuis, S., R. Döffinger, C. Picard, C. Fieschi, F. Altare, E. Jouanguy, L. Abel, and J. L. Casanova. 2000. Human interferon-gamma-mediated immunity is a genetically controlled continuous trait that determines the outcome of mycobacterial invasion. Immunol. Rev. 178: 129-137. (Pubitemid 32095226)
5. Desvignes, L., and J. D. Ernst. 2009. Interferon-gamma-responsive non-hematopoietic cells regulate the immune response to Mycobacterium tuberculosis. Immunity 31: 974-985.
6. Nandi, B., and S. M. Behar. 2011. Regulation of neutrophils by interferon-γ limits lung inflammation during tuberculosis infection. J. Exp. Med. 208: 2251-2262.
7. Stern, J. N., D. B. Keskin, V. Romero, J. Zuniga, L. Encinales, C. Li, C. Awad, and E. J. Yunis. 2009. Molecular signatures distinguishing active from latent tuberculosis in peripheral blood mononuclear cells, after in vitro antigenic stimulation with purified protein derivative of tuberculin (PPD) or Candida: a preliminary report. Immunol. Res. 45: 1-12.
8. Berry, M. P., C. M. Graham, F. W. McNab, Z. Xu, S. A. Bloch, T. Oni, K. A. Wilkinson, R. Banchereau, J. Skinner, R. J. Wilkinson, et al. 2010. An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis. Nature 466: 973-977.
9. Simmons, D. P., D. H. Canaday, Y. Liu, Q. Li, A. Huang, W. H. Boom, and C. V. Harding. 2010. Mycobacterium tuberculosis and TLR2 agonists inhibit induction of type I IFN and class I MHC antigen cross processing by TLR9. J. Immunol. 185: 2405-2415.
10. Prabhakar, S., Y. Qiao, Y. Hoshino, M. Weiden, A. Canova, E. Giacomini, E. Coccia, and R. Pine. 2003. Inhibition of response to alpha interferon by Mycobacterium tuberculosis. Infect. Immun. 71: 2487-2497. (Pubitemid 36519861)
11. Giosué, S., M. Casarini, L. Alemanno, G. Galluccio, P. Mattia, G. Pedicelli, L. Rebek, A. Bisetti, and F. Ameglio. 1998. Effects of aerosolized interferon-alpha in patients with pulmonary tuberculosis. Am. J. Respir. Crit. Care Med. 158: 1156-1162. (Pubitemid 28489016)
12. Palmero, D., K. Eiguchi, P. Rendo, L. Castro Zorrilla, E. Abbate, and L. J. González Montaner. 1999. Phase II trial of recombinant interferon-alpha2b in patients with advanced intractable multidrug-resistant pulmonary tuberculosis: long-term follow-up. Int. J. Tuberc. Lung Dis. 3: 214-218. (Pubitemid 29133046)
13. Ward, C. M., H. Jyonouchi, S. V. Kotenko, S. V. Smirnov, R. Patel, H. Aguila, G. McSherry, B. Dashefsky, and S. M. Holland. 2007. Adjunctive treatment of disseminated Mycobacterium avium complex infection with interferon alpha-2b in a patient with complete interferon-gamma receptor R1 deficiency. Eur. J. Pediatr. 166: 981-985. (Pubitemid 47101344)
14. Telesca, C., M. Angelico, P. Piccolo, L. Nosotti, A. Morrone, C. Longhi, M. Carbone, and L. Baiocchi. 2007. Interferon-alpha treatment of hepatitis D induces tuberculosis exacerbation in an immigrant. J. Infect. 54: e223-e226. (Pubitemid 46420105)
15. Bouchonnet, F., N. Boechat, M. Bonay, and A. J. Hance. 2002. Alpha/beta interferon impairs the ability of human macrophages to control growth of Mycobacterium bovis BCG. Infect. Immun. 70: 3020-3025. (Pubitemid 34564162)
16. Giacomini, E., M. E. Remoli, V. Gafa, M. Pardini, L. Fattorini, and E. M. Coccia. 2009. IFN-beta improves BCG immunogenicity by acting on DC maturation. J. Leukoc. Biol. 85: 462-468.
17. Novikov, A., M. Cardone, R. Thompson, K. Shenderov, K. D. Kirschman, K. D. Mayer-Barber, T. G. Myers, R. L. Rabin, G. Trinchieri, A. Sher, and C. G. Feng. 2011. Mycobacterium tuberculosis triggers host type I IFN signaling to regulate IL-1β production in human macrophages. J. Immunol. 187: 2540-2547.
18. Mayer-Barber, K. D., B. B. Andrade, D. L. Barber, S. Hieny, C. G. Feng, P. Caspar, S. Oland, S. Gordon, and A. Sher. 2011. Innate and adaptive interferons suppress IL-1α and IL-1β production by distinct pulmonary myeloid subsets during Mycobacterium tuberculosis infection. Immunity 35: 1023-1034.
19. Denis, M. 1991. Recombinant murine beta interferon enhances resistance of mice to systemic Mycobacterium avium infection. Infect. Immun. 59: 1857-1859.
20. Manca, C., L. Tsenova, A. Bergtold, S. Freeman, M. Tovey, J. M. Musser, C. E. Barry, III, V. H. Freedman, and G. Kaplan. 2001. Virulence of a Mycobacterium tuberculosis clinical isolate in mice is determined by failure to induce Th1 type immunity and is associated with induction of IFN-alpha/beta. Proc. Natl. Acad. Sci. USA 98: 5752-5757. (Pubitemid 32435714)
21. Kuchtey, J., S. A. Fulton, S. M. Reba, C. V. Harding, and W. H. Boom. 2006. Interferon-alphabeta mediates partial control of early pulmonary Mycobacterium bovis bacillus Calmette-Guérin infection. Immunology 118: 39-49.
22. Ordway, D., M. Henao-Tamayo, M. Harton, G. Palanisamy, J. Troudt, C. Shanley, R. J. Basaraba, and I. M. Orme. 2007. The hypervirulent Mycobacterium tuberculosis strain HN878 induces a potent TH1 response followed by rapid down-regulation. J. Immunol. 179: 522-531. (Pubitemid 46986569)
23. Lee, P. Y., Y. Li, Y. Kumagai, Y. Xu, J. S. Weinstein, E. S. Kellner, D. C. Nacionales, E. J. Butfiloski, N. van Rooijen, S. Akira, et al. 2009. Type I interferon modulates monocyte recruitment and maturation in chronic inflammation. Am. J. Pathol. 175: 2023-2033.
24. Antonelli, L. R., A. Gigliotti Rothfuchs, R. Gonçalves, E. Roffê, A. W. Cheever, A. Bafica, A. M. Salazar, C. G. Feng, and A. Sher. 2010. Intranasal Poly-IC treatment exacerbates tuberculosis in mice through the pulmonary recruitment of a pathogen-permissive monocyte/macrophage population. J. Clin. Invest. 120: 1674-1682.
25. Banaiee, N., E. Z. Kincaid, U. Buchwald, W. R. Jacobs, Jr., and J. D. Ernst. 2006. Potent inhibition of macrophage responses to IFN-gamma by live virulent Mycobacterium tuberculosis is independent of mature mycobacterial lipoproteins but dependent on TLR2. J. Immunol. 176: 3019-3027.
26. Wolf, A. J., B. Linas, G. J. Trevejo-Nuñez, E. Kincaid, T. Tamura, K. Takatsu, and J. D. Ernst. 2007. Mycobacterium tuberculosis infects dendritic cells with high frequency and impairs their function in vivo. J. Immunol. 179: 2509-2519.
27. Palendira, U., A. G. Bean, C. G. Feng, and W. J. Britton. 2002. Lymphocyte recruitment and protective efficacy against pulmonary mycobacterial infection are independent of the route of prior Mycobacterium bovis BCG immunization. Infect. Immun. 70: 1410-1416. (Pubitemid 34163418)
28. Kipnis, A., R. J. Basaraba, I. M. Orme, and A. M. Cooper. 2003. Role of chemokine ligand 2 in the protective response to early murine pulmonary tuberculosis. Immunology 109: 547-551. (Pubitemid 36930170)
29. Swann, J. B., Y. Hayakawa, N. Zerafa, K. C. Sheehan, B. Scott, R. D. Schreiber, P. Hertzog, and M. J. Smyth. 2007. Type I IFN contributes to NK cell homeostasis, activation, and antitumor function. J. Immunol. 178: 7540-7549. (Pubitemid 46898022)
30. Biron, C. A., K. B. Nguyen, G. C. Pien, L. P. Cousens, and T. P. Salazar-Mather. 1999. Natural killer cells in antiviral defense: function and regulation by innate cytokines. Annu. Rev. Immunol. 17: 189-220. (Pubitemid 29241123)
31. Gasser, S., and D. H. Raulet. 2006. Activation and self-tolerance of natural killer cells. Immunol. Rev. 214: 130-142. (Pubitemid 44707907)
32. Schroder, K., P. J. Hertzog, T. Ravasi, and D. A. Hume. 2004. Interferon-gamma: an overview of signals, mechanisms and functions. J. Leukoc. Biol. 75: 163-189. (Pubitemid 38174573)
33. Brod, S. A. 1999. Autoimmunity is a type I interferon-deficiency syndrome corrected by ingested type I IFN via the GALT system. J. Interferon Cytokine Res. 19: 841-852. (Pubitemid 29406636)
34. Kieseier, B. C. 2011. The mechanism of action of interferon-b in relapsing multiple sclerosis. CNS Drugs 25: 491-502.
35. Crow, M. K. 2010. Type I interferon in organ-targeted autoimmune and inflammatory diseases. Arthritis Res. Ther. 12(Suppl. 1): S5.
36. Volkman, H. E., T. C. Pozos, J. Zheng, J. M. Davis, J. F. Rawls, and L. Ramakrishnan. 2010. Tuberculous granuloma induction via interaction of a bacterial secreted protein with host epithelium. Science 327: 466-469.
37. Ling, P. D., M. K. Warren, and S. N. Vogel. 1985. Antagonistic effect of interferon-beta on the interferon-gamma-induced expression of Ia antigen in murine macrophages. J. Immunol. 135: 1857-1863. (Pubitemid 16242999)
38. Rayamajhi, M., J. Humann, K. Penheiter, K. Andreasen, and L. L. Lenz. 2010. Induction of IFN-alphabeta enables Listeria monocytogenes to suppress macrophage activation by IFN-gamma. J. Exp. Med. 207: 327-337.
39. Nguyen, K. B., L. P. Cousens, L. A. Doughty, G. C. Pien, J. E. Durbin, and C. A. Biron. 2000. Interferon alpha/beta-mediated inhibition and promotion of interferon gamma: STAT1 resolves a paradox. Nat. Immunol. 1: 70-76.
40. Wesoly, J., Z. Szweykowska-Kulinska, and H. A. Bluyssen. 2007. STAT activation and differential complex formation dictate selectivity of interferon responses. Acta Biochim. Pol. 54: 27-38. (Pubitemid 46481813)
41. Guarda, G., M. Braun, F. Staehli, A. Tardivel, C. Mattmann, I. Förster, M. Farlik, T. Decker, R. A. Du Pasquier, P. Romero, and J. Tschopp. 2011. Type I interferon inhibits interleukin-1 production and inflammasome activation. Immunity 34: 213-223.
42. Ho, H. H., and L. B. Ivashkiv. 2006. Role of STAT3 in type I interferon responses. Negative regulation of STAT1-dependent inflammatory gene activation. J. Biol. Chem. 281: 14111-14118. (Pubitemid 43848338)
43. Murray, P. J. 2005. The primary mechanism of the IL-10-regulated antiinflammatory response is to selectively inhibit transcription. Proc. Natl. Acad. Sci. USA 102: 8686-8691. (Pubitemid 40862796)
44. Meissner, N., S. Swain, K. McInnerney, S. Han, and A. G. Harmsen. 2010. Type-I IFN signaling suppresses an excessive IFN-gamma response and thus prevents lung damage and chronic inflammation during Pneumocystis (PC) clearance in CD4 T cell-competent mice. Am. J. Pathol. 176: 2806-2818.
45. O'Connell, R. M., S. K. Saha, S. A. Vaidya, K. W. Bruhn, G. A. Miranda, B. Zarnegar, A. K. Perry, B. O. Nguyen, T. F. Lane, T. Taniguchi, et al. 2004. Type I interferon production enhances susceptibility to Listeria monocytogenes infection. J. Exp. Med. 200: 437-445. (Pubitemid 39121901)
46. Auerbuch, V., D. G. Brockstedt, N. Meyer-Morse, M. O'Riordan, and D. A. Portnoy. 2004. Mice lacking the type I interferon receptor are resistant to Listeria monocytogenes. J. Exp. Med. 200: 527-533. (Pubitemid 39121909)
47. Lehner, M., T. Felzmann, K. Clodi, and W. Holter. 2001. Type I interferons in combination with bacterial stimuli induce apoptosis of monocyte-derived dendritic cells. Blood 98: 736-742.
48. Mariotti, S., R. Teloni, E. Iona, L. Fattorini, G. Romagnoli, M. C. Gagliardi, G. Orefici, and R. Nisini. 2004. Mycobacterium tuberculosis diverts alpha interferon-induced monocyte differentiation from dendritic cells into immunoprivileged macrophage-like host cells. Infect. Immun. 72: 4385-4392. (Pubitemid 38989294)
49. Delneste, Y., P. Charbonnier, N. Herbault, G. Magistrelli, G. Caron, J. Y. Bonnefoy, and P. Jeannin. 2003. Interferon-gamma switches monocyte differentiation from dendritic cells to macrophages. Blood 101: 143-150. (Pubitemid 36025900)
50. Stark, G. R., I. M. Kerr, B. R. Williams, R. H. Silverman, and R. D. Schreiber. 1998. How cells respond to interferons. Annu. Rev. Biochem. 67: 227-264. (Pubitemid 28411130)
51. Hamilton, J. A., G. A. Whitty, I. Kola, and P. J. Hertzog. 1996. Endogenous IFN-alpha beta suppresses colony-stimulating factor (CSF)-1-stimulated macrophage DNA synthesis and mediates inhibitory effects of lipopolysaccharide and TNF-alpha. J. Immunol. 156: 2553-2557.
52. Lande, R., E. Giacomini, T. Grassi, M. E. Remoli, E. Iona, M. Miettinen, I. Julkunen, and E. M. Coccia. 2003. IFN-alpha beta released by Mycobacterium tuberculosis-infected human dendritic cells induces the expression of CXCL10: selective recruitment of NK and activated T cells. J. Immunol. 170: 1174-1182. (Pubitemid 36139480)
53. Junqueira-Kipnis, A. P., A. Kipnis, A. Jamieson, M. G. Juarrero, A. Diefenbach, D. H. Raulet, J. Turner, and I. M. Orme. 2003. NK cells respond to pulmonary infection with Mycobacterium tuberculosis, but play a minimal role in protection. J. Immunol. 171: 6039-6045. (Pubitemid 37467223)
54. Feng, C. G., M. Kaviratne, A. G. Rothfuchs, A. Cheever, S. Hieny, H. A. Young, T. A. Wynn, and A. Sher. 2006. NK cell-derived IFN-gamma differentially regulates innate resistance and neutrophil response in T cell-deficient hosts infected with Mycobacterium tuberculosis. J. Immunol. 177: 7086-7093. (Pubitemid 44715076)